Subscribe to Newsletter

Search

Reset Filter

4125 search results for ‘*’

Discovery & Development Drug Discovery

The Tale of Two TULIPs

| Angus Stewart

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Business & Regulation Business Practice

Ad Men of the Round Table

| Angus Stewart

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.

BPS Crowthorne – Helping you maximise your Fill-Finish Capability

| Contributed by BPS Crowthorne

At BPS Crowthorne, we have seen huge growth in demand for our fill-finish products due to our automated services, which provide efficient processes

Business & Regulation Business Practice

A Four Dimensional Perspective

Charlie Badham of 4D Pharma tells us his approach to social media in an age of outrage and tonal mixups.

Business & Regulation Business Practice

HyperReality Check

| Angus Stewart

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

Manufacture Technology and Equipment

The Cobalt-60 Pioneers

| Sponsored by Nordion

Richard Wiens explains the importance of Cobalt-60 in the pharma industry – and why Nordion is a key player in the field

Manufacture Quality & Compliance

Always Watching

| Paul Daniel

Simple and efficient systems for continuous monitoring can make all the difference in developing innovative products.

Manufacture Dosage Forms

Welcome to the Era of Smart Solid Dosages

| Ali Rajabi-Siabhoomi, Gary Pond

On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines.

Manufacture Contract Manufacturing Services

Responding to Changing Needs

| Sponsored by PCI

When it comes to delivering medicines to patients in need, choosing the right packaging partner can make all the difference.

Business & Regulation COVID-19

R&R for an Anti-COVID Europe

| Angus Stewart

The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register